WHOOP raises $575M Series G with LeBron James, Cristiano Ronaldo, and sovereign wealth funds on the cap table
Mar 31, 2026 with Will Ahmed
Key Points
- WHOOP raises $575M Series G led by LeBron James, Cristiano Ronaldo, and sovereign wealth funds Mubadala and QIA to fuel international expansion.
- WHOOP's WHOOP Age score, developed with the Buck Institute, shows 55% of users have biological age younger than chronological age, validating the longevity trend as a core growth driver.
- CEO Will Ahmed positions hardware roadmap around smaller, smarter devices with medical-grade approvals while differentiating on credentialed biological age methodology against flattering competitor apps.
Summary
WHOOP CEO Will Ahmed joined to discuss the company's $575M Series G, which brought in LeBron James, Cristiano Ronaldo, and sovereign wealth funds as new cap table additions. The capital is earmarked primarily for international expansion — Ahmed is direct that brand awareness outside the US is the core gap, and the raise gives WHOOP what he calls the "gunpowder" to fix that.
Product direction
Ahmed frames WHOOP's hardware roadmap around two vectors: getting smaller and getting smarter. The longer-term vision is a device that effectively disappears on the body while expanding its sensing capabilities and adding medical-grade approvals. R&D investment is increasing.
Longevity as a growth driver
The cultural shift toward personal health optimization is doing real commercial work for WHOOP. Ahmed says longevity has become one of the most cited reasons members use the product, and the WHOOP Age score — developed in partnership with the Buck Institute — is now the most screenshotted page in the app. One data point he shares: 55% of WHOOP users have a biological age younger than their chronological age, meaning 45% are tracking older. Ahmed uses that figure to argue the metric isn't flattering users into sharing — it's pushing them.
The peptide and biohacking boom is, in his view, a tailwind rather than a distraction. The underlying driver is the same: people want more control over their health and are frustrated with conventional tools. WHOOP sits inside that broader shift alongside supplements, concierge medicine, and AI health coaching.
The competitive positioning on biological age is worth noting. Ahmed draws a contrast between WHOOP's credentialed methodology and the wave of apps producing implausibly flattering scores — a real risk to category trust as the longevity tracking market grows more crowded.
Ahmed closes by saying the job isn't done, positioning the raise as fuel rather than a finishing line.